Metabolomics Market Size to Reach USD 8.3 Billion by 2032 at 13.2% CAGR

DENVER, Del. - July 16, 2026 - PRLog -- Metabolomics Market Expands as Precision Medicine and Biomarker Research Drive Industry Growth

The global Metabolomics Market is witnessing robust growth as healthcare organizations, pharmaceutical companies, and research institutions increasingly adopt metabolomics technologies to advance precision medicine, biomarker discovery, and drug development. According to the latest Metabolomics Market Report, the market was valued at USD 2.4 Billion in 2022 and is projected to reach USD 8.3 Billion by 2032, registering a CAGR of 13.2% from 2023 to 2032. Growing investments in life sciences research and expanding applications across diagnostics, toxicology, and personalized healthcare continue to accelerate Metabolomics Market Growth.

Metabolomics Market Statistics at a Glance

• Metabolomics Market Size: USD 2.4 Billion in 2022.
• Projected Market Value: USD 8.3 Billion by 2032.
• Forecast CAGR: 13.2% from 2023 to 2032.
• North America remains the largest regional market.
• Asia-Pacific is expected to witness the fastest market growth during the forecast period.

Access PDF Sample Report: https://ln.run/wAIFp

Metabolomics Market Trends Shaping the Future of Healthcare Research

The latest Metabolomics Market Analysis highlights the growing use of advanced analytical technologies such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy to improve metabolite identification and biological data interpretation. Researchers are increasingly integrating metabolomics with genomics, proteomics, and bioinformatics to generate comprehensive insights for disease diagnosis and therapeutic development.

Key Metabolomics Market Trends include expanding applications in precision medicine, increasing demand for biomarker discovery, AI-powered data analysis, systems biology research, and the development of personalized treatment strategies. Continuous technological advancements are enabling faster, more accurate, and high-throughput metabolomic analysis across clinical and research settings.

Pharmaceutical and Biotechnology Research Fuels Market Expansion

The pharmaceutical and biotechnology sectors continue to drive the Metabolomics Market as companies invest in innovative tools to improve drug discovery, clinical research, and disease diagnosis. Metabolomics is increasingly used to identify novel biomarkers, evaluate treatment responses, and support the development of targeted therapies for cancer, cardiovascular disorders, neurological diseases, and metabolic conditions.

Metabolomics Market Report Delivers Strategic Industry Insights

The comprehensive Metabolomics Market Report provides in-depth Metabolomics Market Analysis, covering market size, share, growth drivers, emerging trends, competitive landscape, regional outlook, and future opportunities. The report evaluates key segments by product & service, indication, application, end use, and geography while profiling leading companies shaping the global metabolomics industry.

Full news at Globenewswire: https://www.globenewswire.com/news-release/2023/04/20/2651231/0/en/metabolomics-market-size-growing-at-13-2-cagr-set-to-reach-usd-8-3-billion-by-2032.html